- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01740518
Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy
November 30, 2012 updated by: Dong Il Park, M.D, Ph.D.
Randomized Controlled Trial of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy
The purpose of this study is to compare two regimens of low volume (2L) polyethylene glycol(PEG)plus ascorbic acid versus standard volume (4L) PEG alone for bowel preparation in out-patients
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Inadequate bowel preparation may lead to a longer colonoscopy, and to an inability to identify lesions.
PEG can provide a rapid orthograde peroral approach to colonic lavage without producing significant fluid or electrolyte changes.
Thus PEG is now commonly used for bowel preparation.
However, large amounts and unsatisfactory taste of PEG solution are generally poorly tolerated.
a new low volume PEG-based bowel cleansing agents became available at foreign countries.
Although several studies reported the efficacy and improved compliance of these low volume PEG plus ascorbic acid solution for colonoscopy, but result in Korean patients was not-recognized.
Study Type
Observational
Enrollment (Anticipated)
360
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-746
- Kangbuk Samsung Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Out-patients for colonoscopy in university hospital
Description
Inclusion Criteria:
- Out-patients for colonoscopy
Exclusion Criteria:
- age under 19 years or over 80 years
- Intestinal obstruction
- Women of pregnant, breastfeeding, or at risk of becoming pregnant
- major psychiatric illness
- known allergy to PEG
- serious condition- severe cardiac, renal, or metabolic diseases
- past history of colon resection
- current acute exacerbation of chronic inflammatory bowel disease
- functional constipation defined by Rome III diagnostic criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
PEG + ascorbic acid
Those who taken PEG 2L + ascorbic acid
|
comparison of different solutions for bowel preparation
|
|
PEG 4L
Those who taken PEG 4L alone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The efficacy of bowel preparation
Time Frame: one day (after colonoscopy)
|
three segmental preparation scoring (0~4, Rt., mid, Lt.colon) total preparation grade:A,B,C,D (A or B was defined successful bowel cleansing) Influence of the intake of additional fluid in PEG+ascorbic acid
|
one day (after colonoscopy)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient's compliance and acceptability
Time Frame: one day (after injestion of preparation solution)
|
satisfaction (Visual Analogue Scale) amount of ingestion, frequency and amount of vomiting, tolerability, complication, taste
|
one day (after injestion of preparation solution)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (ANTICIPATED)
December 1, 2012
Study Registration Dates
First Submitted
November 30, 2012
First Submitted That Met QC Criteria
November 30, 2012
First Posted (ESTIMATE)
December 4, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
December 4, 2012
Last Update Submitted That Met QC Criteria
November 30, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ASCPD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.